|
|
US 7,517,527 B2 |
|
| Immunotoxin with in vivo T cell suppressant activity and methods of use |
| David M. Neville, Jr., Bethesda, Md. (US); Jerry Todd Thompson, Goose Creek, S.C. (US); Huaizhong Hu, Bethesda, Md. (US); and Shenglin Ma, Bethesda, Md. (US) |
| Assigned to The United States of America as represented by the Department of Health and Human Services, Washington, D.C. (US) |
| Filed on Sep. 03, 1999, as Appl. No. 9/389,565. |
| Application 09/389565 is a continuation of application No. 08/739703, filed on Oct. 29, 1996, abandoned. |
| Claims priority of provisional application 60/008104, filed on Oct. 30, 1995. |
| Prior Publication US 2003/0157093 A1, Aug. 21, 2003 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. A61K 39/00 (2006.01); C07K 16/00 (2006.01); C12P 21/08 (2006.01)
|